Santa Monica, CA, United States of America

Jeffrey S Wiezorek

This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Kite Pharma, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey S Wiezorek. Retrieved from https://idiyas.com/inventor/jeffrey-s-wiezorek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey S. Wiezorek

Introduction

Jeffrey S. Wiezorek is a prominent inventor based in Santa Monica, California. He has made significant contributions to the field of medical technology, particularly in T cell therapy. With a total of four patents to his name, Wiezorek's work focuses on enhancing the efficacy of treatments for patients in need.

Latest Patents

Wiezorek's latest patents include innovative diagnostic methods for T cell therapy. These inventions provide methods for increasing the efficacy of T cell therapy in patients. They include identifying patients who would respond well to T cell therapy and conditioning patients prior to treatment. The conditioning process involves administering one or more preconditioning agents and identifying biomarker cytokines before the therapy. Another notable patent involves methods of conditioning patients for T cell therapy, specifically through a combination of cyclophosphamide and fludarabine.

Career Highlights

Throughout his career, Wiezorek has worked with notable organizations such as Kite Pharma, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to groundbreaking advancements in medical therapies.

Collaborations

Wiezorek has collaborated with esteemed colleagues, including Adrian I. Bot and William Go. Their combined expertise has furthered the development of innovative solutions in the field of T cell therapy.

Conclusion

Jeffrey S. Wiezorek's contributions to T cell therapy through his patents and collaborations highlight his role as a key innovator in the medical field. His work continues to impact the lives of patients in need of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…